000 02294cam  2200385zi 4500
0019.891374
003CaOODSP
00520221107172850
006m     o  d f      
007cr |||||||||||
008200910e202010##onca    ob   f000 0 eng d
020 |a9780660360126
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-274/2020E-PDF
24500|aPreliminary guidance on key populations for early COVID-19 immunization.
2461 |iAt head of title : |aAn Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cOctober 2020.
264 4|c©2020
300 |a1 online resource (49 pages) : |billustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Orientations préliminaires sur les principales populations à immuniser en priorité contre la COVID-19.
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references (pages 31-33).
520 |a"The objective of this advisory committee statement is to provide preliminary guidance for public health program level decision-making to plan for the efficient, effective, and equitable allocation of a novel coronavirus disease 2019 (COVID-19) vaccine once it is authorized for use in Canada when limited initial vaccine supply will necessitate the prioritization of immunization in some populations earlier than others"--Page 5.
650 0|aCOVID-19 (Disease)|xVaccination|zCanada.
650 0|aCOVID-19 (Disease)|xVaccination|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tOrientations préliminaires sur les principales populations à immuniser en priorité contre la COVID-19.|w(CaOODSP)9.891373
85640|qPDF|s1.90 MB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-274-2020-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-key-populations-early-covid-19-immunization.html